These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 7684427)
21. Application of computerized image analysis in pigmentary skin diseases. Lee ES; Kim JH; Im S; Lee KB; Sohn S; Kang WH Int J Dermatol; 2001 Jan; 40(1):45-9. PubMed ID: 11277953 [TBL] [Abstract][Full Text] [Related]
22. Anatomic distribution of melanocytes in normal nail unit: an immunohistochemical investigation. Perrin C; Michiels JF; Pisani A; Ortonne JP Am J Dermatopathol; 1997 Oct; 19(5):462-7. PubMed ID: 9335239 [TBL] [Abstract][Full Text] [Related]
24. Clinical, pathologic, and ultrastructural studies of progressive macular hypomelanosis. Wu XG; Xu AE; Song XZ; Zheng JH; Wang P; Shen H Int J Dermatol; 2010 Oct; 49(10):1127-32. PubMed ID: 20931684 [TBL] [Abstract][Full Text] [Related]
25. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study. Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999 [TBL] [Abstract][Full Text] [Related]
26. Focal gaps in the basement membrane of involved and uninvolved skin of vitiligo: are they normal? Bose SK; Ortonne JP J Dermatol; 1994 Mar; 21(3):152-9. PubMed ID: 8014268 [TBL] [Abstract][Full Text] [Related]
27. Glabrous lesional stem cells differentiated into functional melanocytes: new hope for repigmentation. Kumar R; Parsad D; Rani S; Bhardwaj S; Srivastav N J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1555-60. PubMed ID: 27538731 [TBL] [Abstract][Full Text] [Related]
28. Further evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. Abdel-Naser MB; Krüger-Krasagakes S; Krasagakis K; Gollnick H; Abdel-Fattah A; Orfanos CE Pigment Cell Res; 1994 Feb; 7(1):1-8. PubMed ID: 8072943 [TBL] [Abstract][Full Text] [Related]
29. Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study. Benzekri L; Hmamouchi I; Gauthier Y Br J Dermatol; 2015 Feb; 172(2):331-6. PubMed ID: 24902987 [TBL] [Abstract][Full Text] [Related]
30. Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo. Wang X; Erf GF J Autoimmun; 2004 Feb; 22(1):21-30. PubMed ID: 14709410 [TBL] [Abstract][Full Text] [Related]
31. Expansion of vitiligo lesions is associated with reduced epidermal CDw60 expression and increased expression of HLA-DR in perilesional skin. Le Poole IC; Stennett LS; Bonish BK; Dee L; Robinson JK; Hernandez C; Hann SK; Nickoloff BJ Br J Dermatol; 2003 Oct; 149(4):739-48. PubMed ID: 14616364 [TBL] [Abstract][Full Text] [Related]
32. Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. Kitamura R; Tsukamoto K; Harada K; Shimizu A; Shimada S; Kobayashi T; Imokawa G J Pathol; 2004 Apr; 202(4):463-75. PubMed ID: 15095274 [TBL] [Abstract][Full Text] [Related]
33. Clinical, histopathological and ultrastructural characteristics of naevus depigmentosus. Xu AE; Huang B; Li YW; Wang P; Shen H Clin Exp Dermatol; 2008 Jul; 33(4):400-5. PubMed ID: 18355354 [TBL] [Abstract][Full Text] [Related]
34. Computerised image analysis of vitiligo lesion: evaluation using manually defined lesion areas. Nugroho H; Ahmad Fadzil MH; Shamsudin N; Hussein SH Skin Res Technol; 2013 Feb; 19(1):e72-7. PubMed ID: 22233154 [TBL] [Abstract][Full Text] [Related]
35. Establishment of a promising vitiligo mouse model for pathogenesis and treatment studies. Fan R; Gao J Diagn Pathol; 2024 Jul; 19(1):92. PubMed ID: 38961434 [TBL] [Abstract][Full Text] [Related]
36. Follicular vitiligo: A report of 8 cases. Gan EY; Cario-André M; Pain C; Goussot JF; Taïeb A; Seneschal J; Ezzedine K J Am Acad Dermatol; 2016 Jun; 74(6):1178-84. PubMed ID: 26830867 [TBL] [Abstract][Full Text] [Related]
37. Autoimmune vitiligo: detection of antibodies to melanin-producing cells. Hertz KC; Gazze LA; Kirkpatrick CH; Katz SI N Engl J Med; 1977 Sep; 297(12):634-7. PubMed ID: 331108 [TBL] [Abstract][Full Text] [Related]
38. Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection. Goldstein NB; Koster MI; Hoaglin LG; Wright MJ; Robinson SE; Robinson WA; Roop DR; Norris DA; Birlea SA Exp Dermatol; 2016 Oct; 25(10):805-11. PubMed ID: 27193292 [TBL] [Abstract][Full Text] [Related]
39. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601 [TBL] [Abstract][Full Text] [Related]
40. Altered levels of Ets-1 transcription factor and matrix metalloproteinases in melanocytes from patients with vitiligo. Kumar R; Parsad D; Kanwar AJ; Kaul D Br J Dermatol; 2011 Aug; 165(2):285-91. PubMed ID: 21428970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]